How VA clinicians treat veterans’ PTSD while managing suicide risk, using shared decisions, safety planning, and phase-based trauma therapies.
|Slideshows|January 28, 2020
7 Measures for Screening and Assessing IPV
Author(s)Julianne Flanagan, PhD, Amber Jarnecke, PhD
Data suggest that it is important for mental health professionals to screen for interpersonal violence and provide relevant treatment referrals. A selection of widely available and validated interpersonal violence screening measures are described in this slideshow.
Advertisement
Advertisement
Related to this article
Learn how IPV shapes mental health from pregnancy to adulthood, and how clinicians assess risk, plan safety, and treat victims and perpetrators.
Open-label extension data show fasedienol appears well tolerated and steadily improves social anxiety scores with as-needed intranasal use, as Vistagen plans FDA discussions.
Phase 3b data show centanafadine reduces adult ADHD and comorbid anxiety.
In this case exploration, a teen survives a gun injury yet denies self-harm, pushing clinicians to read beyond words and plan safety when suicide intent is unclear.
Single-dose DT120 ODT delivers rapid, sustained anxiety relief in phase 3 GAD trial, supporting FDA breakthrough path and NDA plans.
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Adolescent Brain and Schizophrenia: What Research Reveals About Pruning, Dopamine, and Myelin
2
Searching for a New TMS Target in Schizophrenia, With Andrew Pines, MD
3
Using Psychotherapy for the Prevention of Relapse in Schizophrenia
4
Exploring a Misuse of Neuroscience: How Biology Has Been Used to Remove Responsibility in Youth
5